(R)-(-)-10-Methyl-11-hydroxyaporphine: a highly selective serotonergic agonist

Authors:
  • PMPrem Mohan
    Prem Mohan
  • JBJacek Bojarski
    Jacek Bojarski
  • JLJohn Paul Long
    John Paul Long
  • RBRanbir K. Bhatnagar
    Ranbir K. Bhatnagar
  • JFJan R. Flynn
    Jan R. Flynn
  • TCTapan K. Chatterjee
    Tapan K. Chatterjee

Abstract
Prior work in these laboratories identified (.+-.)-5-hydroxy-6-methyl-2-(di-n-propylamino)tetralin as a dopaminergic agonist prodrug. The ortho methyl hydroxy aromatic substitution pattern in this molecule has now been incorporated into the apomorphin ring system to give a congener of the dopaminergic agonist apomorphine in which the position 10 OH group has been replaced by methyl. Preparation of the target compound involved acid-catalyzed rearrangement of the 3-(1-phenyltetrazolyl)ether of morphine and subsequent molecular modification of the product, the 10-(1-phenyltetrazolyl)ether of (R)-(-)-apomorphine. Surprisingly, the target compound elicited no responses in any assays for effects at dopamine receptors, but rather it displayed pharmacological properties consistent with its being a serotonergic agonist with a high degree of selectivity for 5-HT1A receptors similar to the serotonergic agonist 8-hydroxy-2-(di-n-propylamino)tetralin.

This publication has 12 references indexed in Scilit: